润达医疗 - Financials

润达医疗 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
+Revenue	8.3B	9.1B	10.5B	8.9B	7.1B	7.1B	6.0B	4.3B	2.2B	1.6B	1.4B	1.0B	772.0M	631.0M
Revenue Growth %	-9.1%	-12.8%	18.4%	25.3%	0.2%	18.2%	38.1%	99.5%	32.9%	19.9%	32.5%	32.9%	22.3%	--
Total Revenue	8.3B	9.1B	10.5B	8.9B	7.1B	7.1B	6.0B	4.3B	2.2B	1.6B	1.4B	1.0B	772.0M	631.0M
Cost Of Revenue	6.2B	6.7B	7.6B	6.5B	5.2B	5.1B	4.3B	3.1B	1.6B	1.2B	999.0M	737.0M	543.0M	410.0M
+Gross Profit	2.1B	2.4B	2.9B	2.4B	1.9B	1.9B	1.6B	1.2B	609.0M	443.0M	360.0M	289.0M	229.0M	221.0M
Gross Margin %	25.4%	26.6%	28.0%	27.0%	27.0%	27.2%	27.5%	28.2%	28.1%	27.2%	26.5%	28.2%	29.7%	35.0%
Total Operating Cost	8.1B	8.8B	9.9B	8.2B	6.6B	6.5B	5.5B	3.9B	2.0B	1.5B	1.3B	938.0M	699.0M	560.0M
Selling Expenses	841.0M	914.0M	1.0B	845.0M	642.0M	601.0M	441.0M	372.0M	205.0M	156.0M	128.0M	101.0M	80.4M	87.7M
Admin Expenses	480.0M	509.0M	541.0M	398.0M	365.0M	356.0M	320.0M	257.0M	164.0M	110.0M	93.6M	74.3M	61.4M	51.3M
Rd Expenses	116.0M	147.0M	146.0M	123.0M	87.1M	59.5M	44.3M	34.3M	--	--	--	--	--	--
Finance Expenses	313.0M	317.0M	324.0M	292.0M	242.0M	231.0M	188.0M	107.0M	51.0M	33.4M	29.6M	14.0M	6.2M	5.4M
+Operating Income	354.0M	647.0M	816.0M	778.0M	644.0M	677.0M	578.0M	381.0M	174.0M	120.0M	95.9M	88.0M	73.1M	71.2M
Operating Margin %	4.3%	7.1%	7.8%	8.8%	9.1%	9.6%	9.7%	8.8%	8.0%	7.4%	7.1%	8.6%	9.5%	11.3%
Non Operating Income	622,500	17.1M	19.1M	14.6M	11.4M	12.8M	15.5M	7.1M	6.7M	8.1M	7.8M	6.5M	9.4M	2.9M
Non Operating Expenses	9.1M	8.3M	15.8M	12.0M	19.3M	3.9M	1.4M	1.1M	743,600	1.8M	566,900	2.3M	1.1M	164,900
Investment Income	110.0M	232.0M	137.0M	138.0M	140.0M	131.0M	70.1M	9.1M	14.4M	-347,900	-1.8M	--	--	--
Fair Value Change Income	--	--	--	--	-3.6M	-11.2M	-19.8M	-8.0M	--	--	--	--	--	--
Asset Disposal Income	11.5M	11.8M	6.2M	1.7M	5.7M	2.0M	9.2M	-1.9M	168,700	--	--	--	--	--
Asset Impairment Loss	36.2M	34.5M	40.8M	7.3M	737,400	48.5M	108.0M	47.5M	21.1M	19.3M	8.0M	8.1M	4.9M	2.3M
Other Income	33.7M	31.1M	42.6M	16.1M	18.8M	6.9M	4.8M	1.3M	--	--	--	--	--	--
Income Before Tax	346.0M	656.0M	820.0M	780.0M	636.0M	686.0M	592.0M	387.0M	180.0M	126.0M	103.0M	92.2M	81.4M	73.9M
Income Tax	156.0M	213.0M	165.0M	182.0M	132.0M	175.0M	160.0M	89.4M	47.5M	33.5M	28.0M	24.2M	22.5M	19.0M
+Net Income	189.0M	443.0M	655.0M	598.0M	504.0M	511.0M	432.0M	297.0M	132.0M	92.4M	75.1M	67.9M	58.8M	55.0M
Net Margin %	2.3%	4.8%	6.2%	6.7%	7.1%	7.2%	7.2%	6.9%	6.1%	5.7%	5.5%	6.6%	7.6%	8.7%
Net Income Attributable	55.3M	273.0M	418.0M	380.0M	330.0M	310.0M	262.0M	219.0M	116.0M	91.8M	75.2M	67.9M	58.8M	54.5M
Minority Interest	134.0M	169.0M	237.0M	218.0M	174.0M	202.0M	170.0M	78.1M	15.8M	665,100	-55,200	--	17,800	496,600
Eps Basic	0.09	0.47	0.72	0.66	0.57	0.53	0.45	0.38	0.23	0.36	1.07	0.96	0.83	0.82
Eps Diluted	0.09	0.47	0.70	0.64	0.57	0.53	0.45	0.38	0.23	0.36	1.07	0.96	0.83	0.82

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
Cash And Equivalents	1.2B	1.1B	1.0B	1.0B	835.0M	844.0M	373.0M	550.0M	920.0M	190.0M	137.0M	183.0M	119.0M	84.5M
Trading Financial Assets	82.2M	58.0M	106.0M	25.5M	170.0M	120.0M	--	--	--	--	--	--	--	--
Accounts Receivable	5.2B	5.5B	5.9B	3.7B	3.0B	2.8B	2.4B	1.9B	925.0M	570.0M	373.0M	289.0M	190.0M	144.0M
Notes Receivable	129.0M	106.0M	93.1M	133.0M	51.5M	17.5M	26.6M	27.0M	7.6M	1.6M	400,000	--	--	--
Notes And Accounts Receivable	5.3B	5.6B	6.0B	3.8B	3.1B	2.8B	2.4B	1.9B	933.0M	571.0M	374.0M	289.0M	190.0M	144.0M
Prepayments	949.0M	978.0M	809.0M	355.0M	392.0M	240.0M	126.0M	138.0M	105.0M	40.8M	34.6M	25.0M	29.9M	9.5M
Inventory	1.3B	1.4B	1.6B	1.5B	1.2B	1.2B	1.1B	1.0B	674.0M	396.0M	241.0M	177.0M	176.0M	110.0M
Total Current Assets	9.2B	9.4B	9.8B	7.4B	6.2B	5.6B	4.3B	3.8B	2.7B	1.2B	799.0M	682.0M	521.0M	353.0M
Long Term Equity Investment	1.4B	1.2B	1.1B	1.1B	885.0M	506.0M	488.0M	552.0M	194.0M	15.9M	--	--	--	--
Fixed Assets	--	1.1B	962.0M	976.0M	911.0M	863.0M	868.0M	762.0M	567.0M	299.0M	219.0M	122.0M	64.7M	50.0M
Fixed Assets Total	1.0B	1.1B	962.0M	976.0M	911.0M	863.0M	868.0M	762.0M	567.0M	299.0M	219.0M	122.0M	64.7M	50.0M
Construction In Progress	--	18.7M	41.4M	19.3M	21.2M	25.5M	1.1M	6.6M	18.7M	69.5M	18.5M	982,600	2.4M	--
Construction In Progress Total	2.8M	18.7M	41.4M	19.3M	21.2M	25.5M	1.1M	6.6M	18.7M	69.5M	18.5M	982,600	2.4M	--
Intangible Assets	77.3M	76.6M	69.5M	67.7M	60.7M	57.0M	31.6M	32.9M	36.7M	28.6M	25.1M	22.5M	16.4M	470,500
Long Term Deferred Expenses	134.0M	143.0M	118.0M	117.0M	114.0M	102.0M	93.0M	88.6M	9.3M	3.5M	2.2M	2.2M	2.4M	1.8M
Total Non Current Assets	5.1B	4.9B	4.7B	4.6B	3.9B	3.4B	3.3B	3.3B	1.4B	486.0M	286.0M	162.0M	95.9M	61.8M
Total Assets	14.3B	14.3B	14.5B	12.0B	10.2B	9.0B	7.5B	7.1B	4.1B	1.7B	1.1B	844.0M	617.0M	415.0M
Short Term Borrowings	4.9B	4.7B	5.2B	4.2B	3.8B	2.3B	1.5B	1.7B	1.1B	512.0M	280.0M	253.0M	113.0M	71.0M
Accounts Payable	1.2B	1.4B	1.7B	1.1B	758.0M	840.0M	775.0M	356.0M	194.0M	80.4M	164.0M	139.0M	133.0M	25.9M
Advance Receipts	9.0M	14.6M	18.4M	11.7M	7.1M	79.5M	78.2M	73.1M	34.4M	14.3M	11.1M	13.7M	6.7M	7.8M
Contract Liabilities	88.4M	98.6M	168.0M	183.0M	221.0M	--	--	--	--	--	--	--	--	--
Total Current Liabilities	7.5B	7.5B	8.5B	6.2B	5.5B	5.2B	3.6B	3.2B	1.7B	722.0M	556.0M	432.0M	276.0M	130.0M
Long Term Borrowings	662.0M	501.0M	338.0M	448.0M	39.6M	129.0M	252.0M	185.0M	113.0M	5.9M	--	--	--	--
Total Non Current Liabilities	1.2B	1.3B	1.0B	1.4B	553.0M	302.0M	817.0M	1.2B	233.0M	43.5M	53.6M	7.3M	206,700	290,000
Total Liabilities	8.7B	8.9B	9.5B	7.6B	6.1B	5.5B	4.4B	4.4B	1.9B	765.0M	609.0M	440.0M	277.0M	131.0M
Paid In Capital	604.0M	597.0M	580.0M	580.0M	580.0M	580.0M	580.0M	580.0M	322.0M	94.1M	70.5M	70.5M	70.5M	70.5M
Capital Reserve	1.2B	1.2B	921.0M	916.0M	974.0M	972.0M	1.0B	1.0B	1.3B	439.0M	101.0M	101.0M	101.0M	104.0M
Surplus Reserve	116.0M	116.0M	100.0M	94.4M	62.0M	50.1M	41.7M	41.7M	34.8M	24.8M	19.4M	14.7M	10.3M	6.1M
Retained Earnings	2.3B	2.3B	2.2B	1.8B	1.5B	1.2B	860.0M	642.0M	454.0M	366.0M	284.0M	218.0M	158.0M	103.0M
Minority Equity	1.2B	1.2B	1.1B	929.0M	877.0M	758.0M	625.0M	462.0M	105.0M	4.5M	189,800	--	--	59,900
Equity Attributable	4.4B	4.3B	3.9B	3.5B	3.2B	2.8B	2.5B	2.3B	2.1B	924.0M	475.0M	404.0M	340.0M	284.0M
Total Equity	5.6B	5.4B	5.0B	4.4B	4.1B	3.5B	3.1B	2.7B	2.2B	929.0M	476.0M	404.0M	340.0M	284.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
Cash From Sales	9.7B	10.6B	9.9B	9.1B	7.7B	7.5B	6.3B	4.5B	2.3B	1.7B	1.5B	1.1B	854.0M	710.0M
Tax Refunds Received	10.6M	13.4M	22.0M	13.4M	16.3M	5.6M	3.1M	789,800	561,900	142,900	236,200	52,000	5,100	--
Total Operating Cash Inflow	9.8B	10.9B	10.1B	9.4B	7.9B	7.6B	6.4B	4.5B	2.4B	1.7B	1.5B	1.1B	864.0M	714.0M
Cash Paid For Goods	7.1B	7.9B	8.3B	7.1B	6.0B	5.7B	4.6B	3.7B	2.0B	1.6B	1.2B	857.0M	609.0M	521.0M
Cash Paid To Employees	741.0M	754.0M	878.0M	641.0M	450.0M	401.0M	348.0M	271.0M	173.0M	132.0M	102.0M	86.0M	74.5M	57.9M
Taxes Paid	559.0M	560.0M	531.0M	502.0M	423.0M	445.0M	435.0M	260.0M	122.0M	67.8M	63.6M	66.1M	66.3M	47.9M
Total Operating Cash Outflow	9.2B	10.1B	10.5B	9.0B	7.6B	7.3B	5.8B	4.6B	2.5B	1.9B	1.5B	1.1B	825.0M	691.0M
Operating Cash Flow	647.0M	730.0M	-429.0M	371.0M	323.0M	247.0M	539.0M	-87.9M	-125.0M	-227.0M	36.1M	31.6M	38.7M	23.4M
Total Investing Cash Inflow	419.0M	774.0M	747.0M	1.1B	1.5B	1.3B	981.0M	247.0M	66.0M	4.7M	1.9M	6.4M	2.7M	2.4M
Total Investing Cash Outflow	880.0M	1.0B	1.1B	1.5B	2.5B	1.6B	1.3B	2.0B	895.0M	286.0M	127.0M	85.9M	53.0M	30.2M
Investing Cash Flow	-461.0M	-227.0M	-323.0M	-415.0M	-1.0B	-281.0M	-301.0M	-1.8B	-829.0M	-282.0M	-125.0M	-79.5M	-50.4M	-27.8M
Cash From Borrowings	9.2B	9.7B	8.4B	6.3B	5.5B	3.2B	2.5B	2.1B	1.2B	621.0M	397.0M	261.0M	113.0M	71.3M
Dividends And Interest Paid	419.0M	477.0M	294.0M	439.0M	343.0M	319.0M	227.0M	108.0M	73.8M	39.9M	32.8M	17.2M	6.2M	5.3M
Debt Repayments	8.8B	9.8B	7.3B	5.3B	4.2B	2.4B	3.1B	1.4B	617.0M	383.0M	370.0M	121.0M	71.1M	49.0M
Total Financing Cash Inflow	10.0B	10.7B	8.7B	6.5B	5.6B	3.3B	3.0B	3.1B	2.4B	1.0B	444.0M	261.0M	114.0M	120.0M
Total Financing Cash Outflow	9.9B	11.0B	8.2B	6.4B	4.8B	3.1B	3.4B	1.6B	776.0M	451.0M	406.0M	139.0M	77.9M	55.7M
Financing Cash Flow	92.3M	-331.0M	488.0M	94.9M	806.0M	258.0M	-428.0M	1.4B	1.7B	562.0M	38.2M	122.0M	35.7M	64.5M
Net Change In Cash	276.0M	171.0M	-263.0M	49.6M	115.0M	224.0M	-190.0M	-393.0M	714.0M	53.9M	-50.9M	73.9M	24.1M	60.1M
Ending Cash Balance	889.0M	613.0M	442.0M	705.0M	655.0M	540.0M	316.0M	506.0M	898.0M	184.0M	131.0M	181.0M	108.0M	83.5M
Capex	229.0M	320.0M	272.0M	301.0M	332.0M	289.0M	264.0M	346.0M	288.0M	231.0M	125.0M	85.9M	50.0M	22.3M